📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Vical

1.1 - Company Overview

Vical Logo

Vical

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical product research and development based on its patented DNA delivery technologies.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Vical

Diamyd Medical Logo

Diamyd Medical

HQ: Sweden Website
  • Description: Provider of antigen-specific immunotherapies and regenerative therapies for Type 1 Diabetes based on the GAD molecule and GABA technology. Products include Diamyd to preserve insulin production and Remygen for regeneration/immunomodulation. Offers GMP-manufactured GAD65 protein for preclinical research and conducts DIAGNODE-3 (Phase III intralymphatic Diamyd) and DiaPrecise (Phase II prevention) trials.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Diamyd Medical company profile →
Theravectys Logo

Theravectys

HQ: France Website
  • Description: Provider of a proprietary lentiviral vector platform for developing vaccines and immunotherapies to prevent and treat infectious diseases, cancers, and other conditions. Pipeline includes Lenti-HPV-07 (Phase 1) for HPV16/18-induced oropharyngeal and cervical cancers, Lenti-COVID intranasal vaccine for SARS-CoV-2 variants, and LV-DEN tetravalent T-cell dengue vaccine. Initial clinical focus includes HIV/AIDS.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Theravectys company profile →
Agenus Logo

Agenus

HQ: United States Website
  • Description: Provider of immunotherapies and vaccines for cancer and infectious diseases, advancing antibodies that activate antitumor immunity: botensilimab (CTLA-4; Phase 2 in melanoma, MSS colorectal and pancreatic cancers), balstilimab (PD-1; backbone for combinations), zalifrelimab (CTLA-4), AGEN2373 (CD137 agonist), AGEN1571 (ILT-2 antagonist), and an anti-ILT4 antagonist developed with pembrolizumab and chemotherapy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Agenus company profile →
Checkmate Pharmaceuticals Logo

Checkmate Pharmaceuticals

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical research and development focused on cancer immunotherapy, leveraging expertise in CpG oligonucleotides to discover and develop novel immunotherapies aimed at enabling more people with cancer to benefit from these treatments.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Checkmate Pharmaceuticals company profile →
EngMab Logo

EngMab

HQ: United States Website
  • Description: Provider of biotechnology as an independent company funded by private Swiss investors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full EngMab company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Vical

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Vical

2.2 - Growth funds investing in similar companies to Vical

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Vical

4.2 - Public trading comparable groups for Vical

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Vical

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Vical

What does Vical do?

Vical is a provider of biopharmaceutical product research and development based on its patented DNA delivery technologies.

Who are Vical's competitors?

Vical's competitors and similar companies include Diamyd Medical, Theravectys, Agenus, Checkmate Pharmaceuticals, and EngMab.

Where is Vical headquartered?

Vical is headquartered in United States.

How many employees does Vical have?

Vical has 1,000 employees 🔒.

When was Vical founded?

Vical was founded in 2010 🔒.

What sector and industry vertical is Vical in?

Vical is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Vical

Who are the top strategic acquirers in Vical's sector and industry

Top strategic M&A buyers and acquirers in Vical's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Vical?

Top strategic M&A buyers groups and sectors for Vical include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Vical's sector and industry vertical

Which are the top PE firms investing in Vical's sector and industry vertical?

Top PE firms investing in Vical's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Vical's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Vical's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Vical's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Vical include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Vical's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Vical?

The key public trading comparables and valuation benchmarks for Vical include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Vical for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Vical with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Vical's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Vical with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Vical's' sector and industry vertical?

Access recent funding rounds and capital raises in Vical's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Vical